Dr Nicholas Van As: Clinical oncology
Search

Dr Nicholas Van As

Clinical oncology

 

  • Not Fee assured
Overview

Specialises in

  • Urology

About me

Dr Nicholas Van As qualified in medicine in 1995 in South Africa and completed specialist training in clinical oncology at Guy’s and St Thomas’ Hospital, The Royal Marsden and The Institute of Cancer Research.

Dr Van As specialises in urological cancers. He has research interests in stereotactic and image-guided radiotherapy, risk prediction in early prostate cancer, and functional MRI. He has published numerous papers and delivered presentations at international meetings.

Dr Van As is the clinical lead for CyberKnife and leads the stereotactic radiotherapy MDT at The Royal Marsden. He is the chief investigator on the PACE trial. This is the largest international trial looking at stereotactic radiotherapy for prostate cancer. CyberKnife is an exciting new technology which allows the accurate delivery of high-dose image-guided radiotherapy. It has been operational at The Royal Marsden since summer 2011.

Areas of interest

Urological oncology; Radiotherapy; SBRT; SABR; Cyberknife; Systemic therapy for prostate cacner

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

Edit details Print page

The information contained on Finder is submitted by consultants, therapists and facilities, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the data and information on Finder and our website terms of use here.